Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform
暂无分享,去创建一个
[1] J. Bhattacharya,et al. Antibiotic-Loaded Smart Platelet: A Highly Effective Invisible Mode of Killing Both Antibiotic-Sensitive and -Resistant Bacteria , 2022, ACS omega.
[2] Weien Yuan,et al. Clinical progress and advanced research of red blood cells based drug delivery system. , 2021, Biomaterials.
[3] Nikola A. Ivica,et al. Tracking the CAR-T Revolution: Analysis of Clinical Trials of CAR-T and TCR-T Therapies for the Treatment of Cancer (1997–2020) , 2021, Healthcare.
[4] Rosalie M Sterner,et al. CAR-T cell therapy: current limitations and potential strategies , 2021, Blood Cancer Journal.
[5] S. Mitragotri,et al. The evolution of commercial drug delivery technologies , 2021, Nature Biomedical Engineering.
[6] Yu Su,et al. Current Advances and Challenges of Mesenchymal Stem Cells-Based Drug Delivery System and Their Improvements. , 2021, International journal of pharmaceutics.
[7] B. Engelhardt,et al. Biotin-NeutrAvidin Mediated Immobilization of Polymer Micro- and Nanoparticles on T Lymphocytes. , 2021, Bioconjugate chemistry.
[8] H. Klok,et al. Chemical Cell Surface Modification and Analysis of Nanoparticle-Modified Living Cells. , 2021, ACS applied bio materials.
[9] Hongwei Fu,et al. Stem cell and its derivatives as drug delivery vehicles: an effective new strategy of drug delivery system , 2021, All Life.
[10] Jeffrey S. Miller,et al. Exploring the NK cell platform for cancer immunotherapy , 2020, Nature Reviews Clinical Oncology.
[11] M. Smyth,et al. The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies , 2020, Nature Immunology.
[12] J. Liesveld,et al. Stem cell homing: From physiology to therapeutics , 2020, Stem cells.
[13] G. Opdenakker,et al. Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS) , 2020, International journal of molecular sciences.
[14] Xinyu Wang,et al. Microfluidic-mediated nano-drug delivery systems: from fundamentals to fabrication for advanced therapeutic applications. , 2020, Nanoscale.
[15] J. Bueren,et al. Cell Therapy With Mesenchymal Stem Cells Induces an Innate Immune Memory Response That Attenuates Experimental Colitis in the Long Term , 2020, Journal of Crohn's & colitis.
[16] Kai Wang,et al. Targeted Repair of Vascular Injury by Adipose‐Derived Stem Cells Modified with P‐Selectin Binding Peptide , 2020, Advanced science.
[17] Jie Cao,et al. Targeted nanocarriers based on iodinated-cyanine dyes as immunomodulators for synergistic phototherapy. , 2020, Nanoscale.
[18] C. Fu,et al. Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review , 2020, International journal of nanomedicine.
[19] F. Ataullakhanov,et al. Erythrocytes as Carriers: From Drug Delivery to Biosensors , 2020, Pharmaceutics.
[20] Yong Gu Lee,et al. Impaired death receptor signaling in leukemia causes antigen-independent resistance by inducing CAR T cell dysfunction. , 2020, Cancer discovery.
[21] Zhihong Yang,et al. Cell-mediated targeting drugs delivery systems , 2020, Drug delivery.
[22] June. Tracking the CAR-T revolution: Analysis of clinical trials of CAR-T and TCR therapies for the treatment of cancer , 2020 .
[23] B. Baradaran,et al. The effect of Yarrowia lipolytica L-asparaginase on apoptosis induction and inhibition of growth in Burkitt's lymphoma Raji and acute lymphoblastic leukemia MOLT-4 cells. , 2019, International journal of biological macromolecules.
[24] Behnaz Valipour,et al. NK cells: An attractive candidate for cancer therapy , 2019, Journal of cellular physiology.
[25] G. Bardi,et al. Natural Polysaccharide Nanomaterials: An Overview of Their Immunological Properties , 2019, International journal of molecular sciences.
[26] Yanbo Zhang,et al. Mesenchymal Stem Cells for Regenerative Medicine , 2019, Cells.
[27] Yajing Wang,et al. Mesenchymal stem cells-curcumin loaded chitosan nanoparticles hybrid vectors for tumor-tropic therapy. , 2019, International journal of biological macromolecules.
[28] T. Ma,et al. Development of a microdevice-based human mesenchymal stem cell-mediated drug delivery system. , 2019, Biomaterials science.
[29] Gareth R. Williams,et al. Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug delivery , 2019, Journal of Nanobiotechnology.
[30] G. Basturea,et al. Endocytosis , 1985, Springer US.
[31] H. Mandel,et al. Safety and Efficacy of Erythrocyte Encapsulated Thymidine Phosphorylase in Mitochondrial Neurogastrointestinal Encephalomyopathy , 2019, Journal of clinical medicine.
[32] Lin Mei,et al. Efficient lung cancer-targeted drug delivery via a nanoparticle/MSC system , 2018, Acta pharmaceutica Sinica. B.
[33] Byung‐Hyun Cha,et al. Cell surface engineering and application in cell delivery to heart diseases , 2018, Journal of biological engineering.
[34] Ping Gong,et al. Cell-Membrane Immunotherapy Based on Natural Killer Cell Membrane Coated Nanoparticles for the Effective Inhibition of Primary and Abscopal Tumor Growth. , 2018, ACS nano.
[35] Zhen Gu,et al. Cardiac cell–integrated microneedle patch for treating myocardial infarction , 2018, Science Advances.
[36] Quanyin Hu,et al. Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy , 2018, Nature Biomedical Engineering.
[37] M. Chapman,et al. Nanoparticle‐Laden Macrophages for Tumor‐Tropic Drug Delivery , 2018, Advanced materials.
[38] Xiaoyi Sun,et al. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-co-glycolic acid) nanoparticles for glioma-targeting therapy , 2018, International journal of nanomedicine.
[39] J. Isaacs,et al. Concise Review: Mesenchymal Stem Cell‐Based Drug Delivery: The Good, the Bad, the Ugly, and the Promise , 2018, Stem cells translational medicine.
[40] M. Y. Thanuja,et al. Bioengineered cellular and cell membrane‐derived vehicles for actively targeted drug delivery: So near and yet so far , 2018, Advanced drug delivery reviews.
[41] L. Jeng,et al. Role of Insulin-like Growth Factor 1 Receptor Signaling in Stem Cell Stemness and Therapeutic Efficacy , 2018, Cell transplantation.
[42] Jennifer A. Rohrs,et al. CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction , 2018, Cancer Immunology Research.
[43] F. Cuisinier,et al. Dental pulp stem cells used to deliver the anticancer drug paclitaxel , 2018, Stem Cell Research & Therapy.
[44] Ö. Met,et al. Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model , 2018, Oncoimmunology.
[45] M. Sarazin,et al. Neutrophil hyperactivation correlates with Alzheimer's disease progression , 2018, Annals of neurology.
[46] T. Hyeon,et al. General and Facile Coating of Single Cells via Mild Reduction. , 2018, Journal of the American Chemical Society.
[47] G. Golomb,et al. Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases , 2018, Drug Delivery and Translational Research.
[48] T. Iida,et al. The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis , 2017, International journal of molecular sciences.
[49] J. Berlin,et al. Exploiting homing abilities of cell carriers: Targeted delivery of nanoparticles for cancer therapy , 2017, Biochemical pharmacology.
[50] Shukry J. Habib,et al. Wnt ligand presentation and reception: from the stem cell niche to tissue engineering , 2017, Open Biology.
[51] Tithi Ghosh,et al. Tumor promoting role of anti-tumor macrophages in tumor microenvironment. , 2017, Cellular immunology.
[52] Peipei Xu,et al. Doxorubicin-loaded platelets conjugated with anti-CD22 mAbs: a novel targeted delivery system for lymphoma treatment with cardiopulmonary avoidance , 2017, Oncotarget.
[53] H. Lodish,et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease , 2017, Proceedings of the National Academy of Sciences.
[54] C. Dong,et al. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery. , 2017, Small.
[55] S. Geary,et al. Surface engineering tumor cells with adjuvant‐loaded particles for use as cancer vaccines , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[56] Yi Zhang,et al. Tumor-associated macrophages: from basic research to clinical application , 2017, Journal of Hematology & Oncology.
[57] Xunbin Wei,et al. Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse Models , 2017, Stem cells translational medicine.
[58] Liangzhu Feng,et al. Photosensitizer Decorated Red Blood Cells as an Ultrasensitive Light-Responsive Drug Delivery System. , 2017, ACS applied materials & interfaces.
[59] I. Galea,et al. The blood-brain barrier in systemic inflammation , 2017, Brain, Behavior, and Immunity.
[60] Todd M. Allen,et al. Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells. , 2017, Biomaterials.
[61] R. Sackstein,et al. T-Lymphocyte Homing: An Underappreciated yet Critical Hurdle for Successful Cancer Immunotherapy , 2017, Laboratory investigation; a journal of technical methods and pathology.
[62] Zhenjia Wang,et al. Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites , 2017, Theranostics.
[63] Yanyan Jiang,et al. Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer , 2017, Drug delivery.
[64] Sandra C Bustamante López,et al. Characterization of carrier erythrocytes for biosensing applications , 2017, Journal of biomedical optics.
[65] P. Frankel,et al. Neural Stem Cell–Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients , 2016, Clinical Cancer Research.
[66] Samir Mitragotri,et al. Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems. , 2016, Advanced drug delivery reviews.
[67] M. Sitti,et al. Bioengineered and biohybrid bacteria-based systems for drug delivery. , 2016, Advanced drug delivery reviews.
[68] D. Greaves,et al. A novel real time imaging platform to quantify macrophage phagocytosis , 2016, Biochemical pharmacology.
[69] M. Essand,et al. Safe engineering of CAR T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer , 2016, EMBO molecular medicine.
[70] E. Hattingen,et al. ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma. , 2016, Journal of the National Cancer Institute.
[71] A. de Becker,et al. Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? , 2016, World journal of stem cells.
[72] S. Gordon. Phagocytosis: An Immunobiologic Process. , 2016, Immunity.
[73] Jin Gao,et al. Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection. , 2015, ACS nano.
[74] Wei Wang,et al. NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy , 2015, Front. Immunol..
[75] F. Sharp,et al. Targeting Neutrophils in Ischemic Stroke: Translational Insights from Experimental Studies , 2015, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[76] Cheng Dong,et al. Design strategies and applications of circulating cell-mediated drug delivery systems. , 2015, ACS biomaterials science & engineering.
[77] M. Smyth,et al. Balancing natural killer cell activation through paired receptors , 2015, Nature Reviews Immunology.
[78] J. Pollard,et al. Immune cell promotion of metastasis , 2015, Nature Reviews Immunology.
[79] Ashutosh Chilkoti,et al. Co‐opting biology to deliver drugs , 2014, Biotechnology and bioengineering.
[80] Samir Mitragotri,et al. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.
[81] Rajbir Singh,et al. Erythrocytes-based synthetic delivery systems: transition from conventional to novel engineering strategies , 2014, Expert opinion on drug delivery.
[82] P. Rameshwar,et al. Stem cell delivery of therapies for brain disorders , 2014, Clinical and Translational Medicine.
[83] Jeffrey W Pollard,et al. Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.
[84] R. Weinberg,et al. Tackling the cancer stem cells — what challenges do they pose? , 2014, Nature Reviews Drug Discovery.
[85] Kam W. Leong,et al. Whole Blood Cells Loaded with Messenger RNA as an Anti‐Tumor Vaccine , 2014, Advanced healthcare materials.
[86] L. Moretta,et al. Effect of tumor cells and tumor microenvironment on NK‐cell function , 2014, European journal of immunology.
[87] Jennifer A. Prescher,et al. Selective uptake of single walled carbon nanotubes by circulating monocytes for enhanced tumour delivery , 2014, Nature nanotechnology.
[88] QUAN LIU,et al. Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[89] J. Berlin,et al. Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution. , 2014, Future oncology.
[90] J. Kurtzberg,et al. Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[91] Samir Mitragotri,et al. Delivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cells. , 2013, ACS nano.
[92] W. Prasongchean. Introduction to Stem cells and Regenerative Medicine , 2013 .
[93] A. Caplan,et al. MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation , 2013, Stem cells international.
[94] G. Damonte,et al. Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis: A Randomized, Double-blind Sham-controlled Study , 2013, Inflammatory bowel diseases.
[95] R. Casaburi,et al. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. , 2013, Chest.
[96] J. Frank,et al. A first-in-human study of neural stem cells (NSCs) expressing cytosine deaminase (CD) in combination with 5-fluorocytosine (5-FC) in patients with recurrent high-grade glioma. , 2013 .
[97] P. Kubes,et al. Neutrophil recruitment and function in health and inflammation , 2013, Nature Reviews Immunology.
[98] S. H. A. Rizvi,et al. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting , 2013, Journal of drug targeting.
[99] E. D. de Vries,et al. A review on CXCR4/CXCL12 axis in oncology: no place to hide. , 2013, European journal of cancer.
[100] J. Burns,et al. MSC and Tumors: Homing, Differentiation, and Secretion Influence Therapeutic Potential. , 2013, Advances in biochemical engineering/biotechnology.
[101] J. Hubbell,et al. Engineering antigens for in situ erythrocyte binding induces T-cell deletion , 2012, Proceedings of the National Academy of Sciences.
[102] George Kolios,et al. Introduction to Stem Cells and Regenerative Medicine , 2012, Respiration.
[103] Liangfang Zhang,et al. Erythrocyte‐Inspired Delivery Systems , 2012, Advanced healthcare materials.
[104] D. Irvine,et al. Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles. , 2012, Biomaterials.
[105] Yujie Ma,et al. Virus-based nanocarriers for drug delivery. , 2012, Advanced drug delivery reviews.
[106] F. Wenz,et al. Tumor–platelet interaction in solid tumors , 2012, International journal of cancer.
[107] E. Choi,et al. Use of macrophages to deliver therapeutic and imaging contrast agents to tumors. , 2012, Biomaterials.
[108] James J Moon,et al. Engineering Nano‐ and Microparticles to Tune Immunity , 2012, Advanced materials.
[109] S. Kiriakidis,et al. Hypoxia—a key regulator of angiogenesis and inflammation in rheumatoid arthritis , 2012, Nature Reviews Rheumatology.
[110] Robert Franco,et al. International seminar on the red blood cells as vehicles for drugs , 2012, Expert opinion on biological therapy.
[111] L. Zitvogel,et al. Trial watch , 2012, Oncoimmunology.
[112] K. Ley,et al. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. , 2011, Blood.
[113] C. Larochelle,et al. How do immune cells overcome the blood–brain barrier in multiple sclerosis? , 2011, FEBS letters.
[114] S. Rosenberg,et al. Treating cancer with genetically engineered T cells. , 2011, Trends in biotechnology.
[115] P. Kubes,et al. The neutrophil in vascular inflammation , 2011, Nature Medicine.
[116] H. Gendelman,et al. Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease. , 2011, Journal of nanomedicine & nanotechnology.
[117] Wei-Hsin Hsu,et al. Novel geometry type of nanocarriers mitigated the phagocytosis for drug delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[118] Albert Zlotnik,et al. Homeostatic chemokine receptors and organ-specific metastasis , 2011, Nature Reviews Immunology.
[119] Dong Chen,et al. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. , 2011, ACS nano.
[120] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[121] J. Freedman,et al. Platelets and the immune continuum , 2011, Nature Reviews Immunology.
[122] U. A. Ndefo,et al. Sipuleucel-T (provenge) injection: the first immunotherapy agent (vaccine) for hormone-refractory prostate cancer. , 2011, P & T : a peer-reviewed journal for formulary management.
[123] H. Gendelman,et al. Cell-mediated drug delivery , 2011, Expert opinion on drug delivery.
[124] L. Ciaccia. Fundamentals of Inflammation , 2011, The Yale Journal of Biology and Medicine.
[125] A. Hoffman,et al. Efficient Intracellular Delivery of a Pro-Apoptotic Peptide With A pH-Responsive Carrier. , 2011, Reactive & functional polymers.
[126] B Gleich,et al. Human erythrocytes as nanoparticle carriers for magnetic particle imaging , 2010, Physics in medicine and biology.
[127] P. Schiller,et al. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. , 2010, Biomaterials.
[128] P. Kubes,et al. Intravascular Danger Signals Guide Neutrophils to Sites of Sterile Inflammation , 2010, Science.
[129] G. Almeida-Porada,et al. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. , 2010, Advanced drug delivery reviews.
[130] C. Rolny,et al. A chemotactic gradient sequestered on endothelial heparan sulfate induces directional intraluminal crawling of neutrophils. , 2010, Blood.
[131] S. Rankin,et al. Neutrophil kinetics in health and disease , 2010, Trends in immunology.
[132] Soong Ho Um,et al. Therapeutic cell engineering using surface-conjugated synthetic nanoparticles , 2010, Nature Medicine.
[133] D. Brooks,et al. Red blood cell membrane grafting of multi-functional hyperbranched polyglycerols. , 2010, Biomaterials.
[134] A. Giaccia,et al. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease , 2010, Cancer and Metastasis Reviews.
[135] Markus G. Manz,et al. Development of Monocytes, Macrophages, and Dendritic Cells , 2010, Science.
[136] Robert Langer,et al. Nanoparticulate cellular patches for cell-mediated tumoritropic delivery. , 2010, ACS nano.
[137] P. Couvreur,et al. Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.
[138] H. McMahon,et al. Mechanisms of endocytosis. , 2009, Annual review of biochemistry.
[139] J. Ghersi-Egea,et al. The Role of the Choroid Plexus in Neutrophil Invasion after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[140] Alexander Kabanov,et al. Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparmagnetic Iron-Oxide Nanoparticles , 2009, PloS one.
[141] Y. Oh,et al. Opsonized erythrocyte ghosts for liver-targeted delivery of antisense oligodeoxynucleotides. , 2009, Biomaterials.
[142] Soong Ho Um,et al. Surface functionalization of living cells with multilayer patches. , 2008, Nano letters.
[143] L. Borsig. The role of platelet activation in tumor metastasis , 2008, Expert review of anticancer therapy.
[144] M. Andreeff,et al. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells , 2008, Gene Therapy.
[145] M. Cybulsky,et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.
[146] S. Mitragotri,et al. Making polymeric micro- and nanoparticles of complex shapes , 2007, Proceedings of the National Academy of Sciences.
[147] D. Hackam,et al. Toll-like receptor 4 plays a role in macrophage phagocytosis during peritoneal sepsis. , 2007, Journal of pediatric surgery.
[148] A. Koong,et al. Amplification of tumor hypoxic responses by macrophage migration inhibitory factor-dependent hypoxia-inducible factor stabilization. , 2007, Cancer research.
[149] Julia L. Gregory,et al. Macrophage Migration Inhibitory Factor Induces Macrophage Recruitment via CC Chemokine Ligand 21 , 2006, The Journal of Immunology.
[150] U Teichgräber,et al. Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. , 2006, Nano letters.
[151] A. Steinkasserer,et al. Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation. , 2006, Journal of immunological methods.
[152] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[153] R. Alon,et al. Immune cell migration in inflammation: present and future therapeutic targets , 2005, Nature Immunology.
[154] C. Lewis,et al. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.
[155] F. Chen,et al. Analysis of amino acids in individual wheat embryonic protoplast , 2005, Amino Acids.
[156] M. Smyth,et al. Activation of NK cell cytotoxicity. , 2005, Molecular immunology.
[157] Samir Mitragotri,et al. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[158] R. Barber,et al. Cerebral Neutrophil Recruitment, Histology, and Outcome in Acute Ischemic Stroke: An Imaging-Based Study , 2004, Stroke.
[159] P. Cullis,et al. Drug Delivery Systems: Entering the Mainstream , 2004, Science.
[160] A. Palamara,et al. Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections. , 2003, The Journal of antimicrobial chemotherapy.
[161] M. Barry,et al. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[162] J. Gehl,et al. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. , 2003, Acta physiologica Scandinavica.
[163] Mehrdad Hamidi,et al. Carrier Erythrocytes: An Overview , 2003, Drug delivery.
[164] E. de Vries,et al. A potential role of macrophage activation in the treatment of cancer. , 2002, Critical reviews in oncology/hematology.
[165] C. van Broeckhoven,et al. Messenger RNA Electroporation of Human Monocytes, Followed by Rapid In Vitro Differentiation, Leads to Highly Stimulatory Antigen-Loaded Mature Dendritic Cells1 , 2002, The Journal of Immunology.
[166] L Bigi,et al. Erythrocyte‐mediated delivery of dexamethasone in patients with chronic obstructive pulmonary disease , 2001, Biotechnology and applied biochemistry.
[167] M. Pinilla,et al. Mouse erythrocytes as carriers for coencapsulated alcohol and aldehyde dehydrogenase obtained by electroporation in vivo survival rate in circulation, organ distribution and ethanol degradation. , 2001, Life sciences.
[168] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[169] M. Pinilla,et al. In vitro and in vivo study of glutamate dehydrogenase encapsulated into mouse erythrocytes by a hypotonic dialysis procedure. , 1999, Life sciences.
[170] H. Sakahara,et al. Avidin-biotin system for delivery of diagnostic agents. , 1999, Advanced drug delivery reviews.
[171] A. Lanzavecchia,et al. From TCR Engagement to T Cell Activation A Kinetic View of T Cell Behavior , 1999, Cell.
[172] A. Aderem,et al. Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.
[173] C Lizano,et al. In vitro study of alcohol dehydrogenase and acetaldehyde dehydrogenase encapsulated into human erythrocytes by an electroporation procedure. , 1998, Biochimica et biophysica acta.
[174] M. Cremonesi,et al. Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity. , 1998, British Journal of Cancer.
[175] John A. Smith. Neutrophils, host defense, and inflammation: a double‐edged sword , 1994, Journal of leukocyte biology.
[176] P. Kochanek,et al. Neutrophil accumulation after traumatic brain injury in rats: comparison of weight drop and controlled cortical impact models. , 1994, Journal of neurotrauma.
[177] T. Carlos,et al. Leukocyte-endothelial adhesion molecules. , 1994, Blood.
[178] T. Standiford,et al. Cytokines. 2. Cytokines and lung inflammation: mechanisms of neutrophil recruitment to the lung. , 1993, Thorax.
[179] A. Chait,et al. Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[180] R H Glew,et al. Enzyme loading of erythrocytes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.